NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AMLo Biosciences

AMLo Biosciences

Private
Newcastle upon TyneHealthcare & Life Scienceshttps://amlo-biosciences.com/

Last Round

VC Round

Nov 28, 2022

Total Funding Raised

$5.2M

Company Overview

AMLo Biosciences is a biotechnology company that develops prognostic tests for the early detection of skin cancers with metastatic potential.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

prognostic testmelanoma prognostic testearly-stage melanomaskin cancer diagnosticsbiomarker testingpatient stratificationmedtechprotein biomarkerscancer Dximmunohistochemical assayIHC testmedical devicecutaneous squamous cell carcinomacSCCoropharyngeal squamous cell carcinomaOPSCC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMLo Biosciences Comparables

Compare AMLo Biosciences with similar companies based on industry and business-model similarity.

AMLo Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SkylineDx
81%
Castle Biosciences, Inc.
75%
Myriad Genetics
68%

AMLo Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 28, 2022
Series AApr 20, 2022
SeedNov 23, 2020
SeedOct 11, 2018

AMLo Biosciences Investors

Notable investors and investment history

AMLo Biosciences investors
InvestorRounds
Ascension VenturesSeries A
Future Planet Capital RegionalSeries A
EsperanteSeries A, Seed, VC Round
Northstar VenturesSeries A, Seed, VC Round
Milltrust International GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 28, 2022

    $1.93M raised in a VC Round.

  • Apr 20, 2022

    $3.2M round completed.

AMLo Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMLo Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMLo Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewcastle upon Tyne
Year Founded2017
Last FundingNov 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.